Eagle Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$24.4M Buy
29,394
+7,425
+34% +$6.68M 0.12% 165
2024
Q2
$20.1M Buy
21,969
+1,641
+8% +$1.31M 0.11% 179
2024
Q1
$15.5M Sell
20,328
-218
-1% -$155K 0.08% 221
2023
Q4
$12M Sell
20,546
-728
-3% -$425K 0.06% 250
2023
Q3
$11.4M Buy
21,274
+5,772
+37% +$2.97M 0.07% 238
2023
Q2
$7.27M Buy
15,502
+10,352
+201% +$4.34M 0.04% 305
2023
Q1
$1.77M Buy
5,150
+820
+19% +$277K 0.01% 447
2022
Q4
$1.58M Buy
4,330
+356
+9% +$126K 0.01% 446
2022
Q3
$1.28M Sell
3,974
-216
-5% -$68.4K 0.01% 462
2022
Q2
$1.36M Sell
4,190
-222
-5% -$66.6K 0.01% 470
2022
Q1
$1.26M Sell
4,412
-20,071
-82% -$5.17M 0.01% 499
2021
Q4
$6.79M Sell
24,483
-156
-0.6% -$39.5K 0.03% 367
2021
Q3
$5.69M Sell
24,639
-336,979
-93% -$83.2M 0.03% 384
2021
Q2
$83M Buy
361,618
+1,272
+0.4% +$256K 0.36% 110
2021
Q1
$66.8M Buy
360,346
+183,627
+104% +$35.9M 0.3% 131
2020
Q4
$29.8M Sell
176,719
-505,578
-74% -$75.5M 0.17% 187
2020
Q3
$99.8M Buy
682,297
+34,137
+5% +$5.28M 0.51% 72
2020
Q2
$105M Sell
648,160
-31,629
-5% -$4.86M 0.6% 50
2020
Q1
$94.3M Buy
679,789
+430,926
+173% +$59.2M 0.59% 48
2019
Q4
$32.7M Sell
248,863
-2,273
-0.9% -$263K 0.16% 203
2019
Q3
$28.1M Buy
251,136
+234,305
+1,392% +$26.1M 0.14% 206
2019
Q2
$1.86M Buy
16,831
+215
+1% +$25.3K 0.01% 525
2019
Q1
$2.16M Buy
16,616
+2,156
+15% +$262K 0.01% 501
2018
Q4
$1.67M Buy
+14,460
New +$1.62M 0.01% 507

Other funds holding LLY

Eagle Asset Management's LLY Position: Q3 2024 in Review

Eagle Asset Management increased its Eli Lilly (LLY) stake by 34% in Q3 2024, buying an estimated $6.68M and bringing the position to 29,394 shares worth $24.4M. The position accounts for 0.12% of the portfolio, ranked #165.

Eagle Asset Management first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $105M in Q2 2020. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Eagle Asset Management held 29,394 shares of Eli Lilly worth $24.4M as of Q3 2024.
  • Eagle Asset Management bought 7,425 Eli Lilly shares in Q3 2024, an estimated $6.68M.
  • Eli Lilly made up 0.12% of Eagle Asset Management's portfolio in Q3 2024, its #165 holding.
  • Eagle Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • Eagle Asset Management's Eli Lilly position peaked at $105M in Q2 2020.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.